跳至主要内容
临床试验/JPRN-jRCT2080220144
JPRN-jRCT2080220144未知3 期

Clinical Study to assess the efficacy and safety of increased dose of TA-650 in patients with Rheumatoid Arthritis

Mitsubishi Tanabe Pharma Corporation0 个研究点开始时间: 2005年10月12日最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 75age old(—)
性别
All

入选标准

  • [Inclusion criteria]
  • Patients with active Rheumatoid Arthritis in spite of treatment with methotrexate, 20 to 75 years of age, males and females.
  • [Exclusion criteria]
  • Patients who have received infliximab in the past, have a history of serious infection which caused hospitalization within 6 months before the registration, have an active tuberculosis, have a complication or a history of malignancy within 5 years before the registration.

排除标准

  • 未提供

研究者

相似试验